» Articles » PMID: 23911704

Nucleosomes and Neutrophil Activation in Sickle Cell Disease Painful Crisis

Overview
Journal Haematologica
Specialty Hematology
Date 2013 Aug 6
PMID 23911704
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Activated polymorphonuclear neutrophils play an important role in the pathogenesis of vaso-occlusive painful sickle cell crisis. Upon activation, polymorphonuclear neutrophils can form neutrophil extracellular traps. Neutrophil extracellular traps consist of a meshwork of extracellular DNA, nucleosomes, histones and neutrophil proteases. Neutrophil extracellular traps have been demonstrated to be toxic to endothelial and parenchymal cells. This prospective cohort study was conducted to determine neutrophil extracellular trap formation in sickle cell patients during steady state and painful crisis. As a measure of neutrophil extracellular traps, plasma nucleosomes levels were determined and polymorphonuclear neutrophil activation was assessed measuring plasma levels of elastase-α1-antitrypsin complexes in 74 patients in steady state, 70 patients during painful crisis, and 24 race-matched controls using Enzyme Linked Immunosorbent Assay. Nucleosome levels in steady state sickle cell patients were significantly higher than levels in controls. During painful crisis levels of both nucleosomes and elastase-α1-antitrypsin complexes increased significantly. Levels of nucleosomes correlated significantly to elastase-α1-antitrypsin complex levels during painful crisis, (Sr = 0.654, P<0.001). This was seen in both HbSS/HbSβ(0)-thalassemia (Sr=0.55, P<0.001) and HbSC/HbSβ(+-)thalassemia patients (Sr=0.90, P<0.001) during painful crisis. Levels of nucleosomes showed a correlation with length of hospital stay and were highest in patients with acute chest syndrome. These data support the concept that neutrophil extracellular trap formation and neutrophil activation may play a role in the pathogenesis of painful sickle cell crisis and acute chest syndrome.

Citing Articles

Prospective study of complement activation and thromboinflammation within sickle cell disease and its complications.

Varelas C, Vlachaki E, Klonizakis P, Pantelidou D, Minti F, Diamantidis M Hemasphere. 2024; 8(7):e135.

PMID: 39055645 PMC: 11270009. DOI: 10.1002/hem3.135.


Circulating Iron in Patients with Sickle Cell Disease Mediates the Release of Neutrophil Extracellular Traps.

Van Avondt K, Schimmel M, Bulder I, van Mierlo G, Nur E, van Bruggen R Transfus Med Hemother. 2023; 50(4):321-329.

PMID: 37767280 PMC: 10521246. DOI: 10.1159/000526760.


Oxidative Stress in Healthy and Pathological Red Blood Cells.

Orrico F, Laurance S, Lopez A, Lefevre S, Thomson L, Moller M Biomolecules. 2023; 13(8).

PMID: 37627327 PMC: 10452114. DOI: 10.3390/biom13081262.


Extracellular Vesicles in Sickle Cell Disease: A Promising Tool.

Lamarre Y, Nader E, Connes P, Romana M, Garnier Y Bioengineering (Basel). 2022; 9(9).

PMID: 36134985 PMC: 9495982. DOI: 10.3390/bioengineering9090439.


The NLRP3 inflammasome fires up heme-induced inflammation in hemolytic conditions.

Salgar S, Bolivar B, Flanagan J, Anum S, Bouchier-Hayes L Transl Res. 2022; 252:34-44.

PMID: 36041706 PMC: 10351365. DOI: 10.1016/j.trsl.2022.08.011.


References
1.
Haynes Jr J, Obiako B, King J, Hester R, Ofori-Acquah S . Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells. Am J Physiol Heart Circ Physiol. 2006; 291(4):H1679-85. DOI: 10.1152/ajpheart.00256.2006. View

2.
von Bruhl M, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M . Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012; 209(4):819-35. PMC: 3328366. DOI: 10.1084/jem.20112322. View

3.
Fuchs T, Kremer Hovinga J, Schatzberg D, Wagner D, Lammle B . Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood. 2012; 120(6):1157-64. PMC: 3418712. DOI: 10.1182/blood-2012-02-412197. View

4.
Ballas S, LEWIS C, Noone A, Krasnow S, Kamarulzaman E, Burka E . Clinical, hematological, and biochemical features of Hb SC disease. Am J Hematol. 1982; 13(1):37-51. DOI: 10.1002/ajh.2830130106. View

5.
Brittain J, Knoll C, Ataga K, Orringer E, Parise L . Fibronectin bridges monocytes and reticulocytes via integrin alpha4beta1. Br J Haematol. 2008; 141(6):872-81. DOI: 10.1111/j.1365-2141.2008.07056.x. View